OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
600699 Ningbo Joyson Electronic Corp.
- 17.67
- -0.28-1.56%
Not Open Apr 1 15:00 CST
24.89BMarket Cap25.91P/E (TTM)
18.11High17.56Low217.01KlotVolume18.11Open17.95Pre Close384.84MTurnover1.59%Turnover Ratio25.91P/E (Static)1.41BShares20.9052wk High1.84P/B24.17BFloat Cap13.3352wk Low19.75Limit Up1.37BShs Float40.87Historical High16.16Limit Down3.06%Amplitude0.50Historical Low0.26Dividend TTM17.73Avg Price115.62KlotAsk1.47%Div YieldTTM100Lot Size93.01KlotBid
Ningbo Joyson Electronic Corp. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.24%55.86B | -0.42%41.13B | 0.24%27.08B | 0.42%13.28B | 11.92%55.73B | 15.57%41.31B | 17.86%27.01B | 12.72%13.22B | 9.03%49.79B | 4.80%35.74B |
| Operating revenue | 0.24%55.86B | -0.42%41.13B | 0.24%27.08B | 0.42%13.28B | 11.92%55.73B | 15.57%41.31B | 17.86%27.01B | 12.72%13.22B | 9.03%49.79B | 4.80%35.74B |
| Other operating revenue | ---- | ---- | 77.77%179.64M | ---- | ---- | ---- | -7.17%101.05M | ---- | -54.28%296.71M | ---- |
| Total operating cost | -0.43%54.11B | -2.40%39.51B | -2.04%26.01B | -2.14%12.83B | 9.06%54.34B | 13.16%40.48B | 14.15%26.55B | 8.50%13.11B | 4.34%49.82B | 3.82%35.77B |
| Operating cost | -1.83%46.8B | -2.33%34.72B | -2.18%22.88B | -2.52%11.22B | 8.74%47.67B | 13.04%35.55B | 14.58%23.39B | 10.07%11.51B | 8.62%43.84B | 6.27%31.45B |
| Operating tax surcharges | 44.89%232.19M | 51.39%168.42M | 54.61%104.36M | 12.54%38.79M | 13.60%160.25M | 16.80%111.25M | 3.96%67.5M | -14.79%34.46M | 15.43%141.06M | 16.37%95.25M |
| Operating expense | 33.68%584.39M | -8.56%398.26M | -12.98%267.03M | 45.25%144.52M | -48.28%437.15M | -15.89%435.57M | -7.19%306.85M | -38.42%99.5M | -28.65%845.17M | -13.13%517.87M |
| Administration expense | 16.67%3.08B | -8.59%1.81B | -2.24%1.21B | -1.48%610.46M | 10.69%2.64B | 10.64%1.99B | -0.12%1.24B | -13.87%619.63M | -13.85%2.38B | -7.69%1.79B |
| Financial expense | -6.96%827.84M | -3.56%630.45M | -1.74%417.62M | -21.49%210.92M | 86.33%889.77M | 147.66%653.73M | 189.18%425.04M | 80.18%268.65M | -50.86%477.53M | -51.27%263.96M |
| -Interest expense (Financial expense) | 0.85%1.13B | -0.06%864.09M | -5.07%574.32M | 7.10%293.35M | 20.25%1.12B | 32.05%864.57M | 32.68%605M | 30.26%273.91M | -9.17%932.11M | -10.46%654.71M |
| -Interest Income (Financial expense) | -39.07%-105.13M | 1.92%-73.14M | 11.62%-62.51M | 19.69%-23.08M | 20.43%-75.59M | 3.25%-74.57M | 5.77%-70.73M | 7.36%-28.74M | -5.28%-95M | -7.35%-77.08M |
| Research and development | 1.71%2.58B | 1.59%1.77B | 0.51%1.13B | 4.63%604.88M | 18.83%2.54B | 5.54%1.74B | 5.62%1.12B | 4.01%578.12M | -8.86%2.14B | -2.70%1.65B |
| Credit Impairment Loss | 9.88%-32.43M | 35.31%-16.34M | -43.53%-10.95M | -493.09%-4.49M | -328.34%-35.99M | -1,144.13%-25.25M | -615.32%-7.63M | -136.77%-757.61K | 144.26%15.76M | -80.32%2.42M |
| Asset Impairment Loss | -98.03%-247.65M | -381.71%-113.2M | -854.54%-80.77M | 16.03%-18.77M | -153.87%-125.06M | -215.14%-23.5M | -127.95%-8.46M | -241.35%-22.35M | 97.65%-49.26M | 135.10%20.41M |
| Other net revenue | -35.12%246.12M | -56.51%148.82M | -73.54%64.17M | -44.15%66.97M | 17.92%379.34M | 41.91%342.19M | 46.78%242.53M | 41.22%119.9M | 117.90%321.7M | 74.36%241.14M |
| Fair value change income | -76.54%36.87M | -77.79%27.87M | -87.78%13.09M | -71.47%17.7M | 54.38%157.13M | 282.33%125.52M | 2,330.82%107.13M | 225.55%62.02M | 61.06%101.78M | 39.24%32.83M |
| Invest income | 22.58%251.23M | -40.55%90.99M | -17.87%57.15M | 12.93%33.04M | 64.66%204.95M | 79.49%153.06M | 33.20%69.58M | 42.05%29.26M | -22.92%124.47M | -12.57%85.27M |
| -Including: Investment income associates | -23.08%116.64M | -21.34%89.13M | -17.18%55.09M | 15.63%32.24M | 34.09%151.63M | 57.21%113.31M | 66.81%66.52M | 92.47%27.88M | 5.27%113.08M | 16.17%72.08M |
| Asset deal income | -52.01%13.73M | 68.80%13.05M | 252.73%901.83K | 233.97%2.59M | 266.81%28.61M | 125.06%7.73M | -128.86%-590.46K | -71.97%-1.93M | 158.65%7.8M | 957.36%3.44M |
| Other revenue | 49.89%224.37M | 39.96%146.45M | 2.73%84.75M | -31.24%36.9M | 23.56%149.7M | 8.12%104.63M | 10.31%82.49M | 88.30%53.67M | 0.49%121.15M | 54.32%96.77M |
| Operating profit | 13.18%2B | 51.62%1.78B | 60.45%1.14B | 121.15%516.78M | 507.41%1.77B | 458.18%1.17B | 510.29%707.53M | 187.53%233.68M | 107.52%291.56M | 199.32%209.87M |
| Add:Non operating Income | -40.65%5.51M | -22.02%6.89M | 13.86%4.65M | -31.30%2.27M | -95.37%9.28M | 50.53%8.84M | -13.85%4.08M | 694.48%3.3M | 7,071.35%200.46M | 95.83%5.87M |
| Less:Non operating expense | -21.61%14.07M | 148.32%11.04M | 60.32%3.79M | -43.24%1.08M | 47.08%17.94M | 5.59%4.45M | -30.72%2.36M | 398.68%1.9M | -13.63%12.2M | 22.99%4.21M |
| Total profit | 13.25%2B | 50.70%1.77B | 60.18%1.14B | 120.34%517.97M | 267.28%1.76B | 455.87%1.18B | 514.47%709.25M | 188.07%235.08M | 112.34%479.82M | 199.90%211.53M |
| Less:Income tax cost | 28.20%669.47M | 66.35%509.08M | 40.78%298.48M | 200.62%137.78M | 111.79%522.19M | 39.34%306.03M | 131.21%212.02M | 15.98%45.83M | -61.84%246.56M | 166.36%219.63M |
| Net profit | 6.95%1.33B | 45.19%1.26B | 68.46%837.62M | 100.89%380.18M | 431.63%1.24B | 10,842.14%869.81M | 289.19%497.23M | 161.75%189.24M | 105.14%233.26M | 97.25%-8.1M |
| Net profit from continuing operation | 6.95%1.33B | 45.19%1.26B | 68.46%837.62M | 100.89%380.18M | 431.63%1.24B | 10,842.14%869.81M | 289.19%497.23M | 161.75%189.24M | 105.14%233.26M | 97.25%-8.1M |
| Less:Minority Profit | 133.15%365.81M | 252.83%321.4M | 824.59%200.85M | 773.32%73.68M | 197.50%156.9M | 165.50%91.09M | 113.81%21.72M | 92.63%-10.94M | 79.43%-160.92M | 55.46%-139.08M |
| Net profit of parent company owners | -11.33%960.47M | 20.90%941.5M | 33.91%636.77M | 53.11%306.5M | 174.79%1.08B | 494.54%778.72M | 550.76%475.51M | 226.72%200.19M | 110.50%394.18M | 625.56%130.98M |
| Earning per share | ||||||||||
| Basic earning per share | -11.54%0.69 | 19.64%0.67 | 28.57%0.45 | 46.67%0.22 | 168.97%0.78 | 460.00%0.56 | 537.50%0.35 | 225.00%0.15 | 110.58%0.29 | 900.00%0.1 |
| Diluted earning per share | -11.54%0.69 | 19.64%0.67 | 28.57%0.45 | 46.67%0.22 | 168.97%0.78 | 460.00%0.56 | 537.50%0.35 | 225.00%0.15 | 110.58%0.29 | 900.00%0.1 |
| Other composite income | -1,487.83%-847.51M | -571.15%-692.92M | -146.51%-203.69M | -62.55%-279.25M | -93.50%61.07M | -78.49%147.07M | 374.86%437.9M | -174.43%-171.8M | 346.25%939.42M | 215.83%683.87M |
| Other composite income of parent company owners | -2,377.69%-463.76M | -304.53%-452.73M | -140.08%-145.97M | -310.66%-245.61M | -96.89%20.36M | -50.68%221.35M | 175.93%364.2M | -128.82%-59.81M | 337.04%655.24M | 184.42%448.83M |
| Other composite income of minority owners | -1,042.73%-383.75M | -223.34%-240.19M | -178.32%-57.72M | 69.96%-33.64M | -85.68%40.71M | -131.61%-74.28M | 285.29%73.7M | -580.42%-111.99M | 370.50%284.18M | 500.30%235.03M |
| Total composite income | -63.20%478.77M | -43.95%569.99M | -32.21%633.93M | 478.45%100.93M | 10.96%1.3B | 50.48%1.02B | 648.11%935.13M | 123.07%17.45M | 123.85%1.17B | 176.39%675.77M |
| Total composite income of parent company owners | -54.99%496.71M | -51.13%488.77M | -41.55%490.8M | -56.63%60.89M | 5.16%1.1B | 72.48%1B | 3,068.73%839.71M | 183.31%140.38M | 126.04%1.05B | 212.89%579.81M |
| Total composite income of minority owners | -109.08%-17.94M | 383.15%81.21M | 50.00%143.13M | 132.57%40.04M | 60.32%197.61M | -82.48%16.81M | 148.41%95.42M | 1.79%-122.93M | 113.89%123.26M | 125.87%95.96M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.